Displaying 1 to 20 of 114 investments
Country Date Notes
Acceleron Pharma Inc
Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.
United States 1 Dec 2009 Series D
Follow-on investment. Round participant. Active
Acceleron Pharma Inc
Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.
United States 1 Dec 2011 Series F
Initial investment. Round participant. Active
Acceleron Pharma Inc
Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.
United States 1 Jun 2010 Series E
Follow-on investment. Active
Acceleron Pharma Inc
Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.
United States 1 Aug 2006 Series B
Initial investment. Round participant. Active
Acceleron Pharma Inc
Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.
United States 1 Oct 2007 Series C
Initial investment. Round participant. Active
Adiana Inc
United States 25 Aug 2005 Series D
Active
Adimab LLC
Developer of a human antibody discovery platform in yeast.
United States 1 Oct 2009 Series D
Active
Adolor Corp
United States N/A
Active
Aerogen
Medical device and drug delivery company
United States N/A
Active
Affimed Therapeutics AG
Antibody therapeutics for cancer and inflammatory diseases.
Germany N/A
Agensys Inc
United States 1 Jul 2007 Series D
Active
Amarin Pharmaceuticals Inc
Ireland N/A
Ambit Biosciences Inc
A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer.
United States 10 Jun 2011 Series D
Amnis Corp
A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology.
United States 1 Aug 2005 Series C
Amnis Corp
A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology.
United States 1 Jul 2009 Series D
Amnis Corp
A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology.
United States 1 Dec 2001 Series B
Anthera Pharmaceuticals Inc
United States N/A
Active
Aragon Pharmaceuticals Inc
Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company.
United States N/A
Arena Pharmaceuticals Inc
United States N/A
arGEN-X BV
Innovation-driven biopharmaceutical company.
Netherlands N/A